N-Benzyl 1-BOC-piperidine-4-carboxamide

Catalog No. :
ACUEFQ687
CAS No. :
188527-08-4
Molecular Formula :
C18H26N2O3
Molecular Weight :
318.42

IUPAC Name:tert-butyl 4-(benzylcarbamoyl)piperidine-1-carboxylate

N-Benzyl 1-BOC-piperidine-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$191.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Benzyl 1-BOC-piperidine-4-carboxamide
IUPAC Nametert-butyl 4-(benzylcarbamoyl)piperidine-1-carboxylate
MDL No.0
Molecular FormulaC18H26N2O3
Molecular Weight318.42
SMILESO=C(C1CCN(C(OC(C)(C)C)=O)CC1)NCC2=CC=CC=C2
InChI KeyAGQWIWVWFLIEKQ-UHFFFAOYSA-N
SynonymN-Benzyl 1-BOC-piperidine-4-carboxaMide;N-benzyl-1-(tert-butoxycarbonyl)piperidine-4-carboxamide;tert-butyl 4-[(benzylamino)carbonyl]-1-piperidinecarboxylate;1-Piperidinecarboxylic acid, 4-[[(phenylmethyl)amino]carbonyl]-, 1,1-dimethylethyl ester;tert-butyl 4-(benzylcarbamoyl)piperidine-1-carboxylate
CAS No.188527-08-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUEFQ687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYPX863 route compound structure diagram
    ACKYPX86384358-13-4 In Stock
  2. Plus
  3. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7 In Stock
  4. Then
  5. ACUEFQ687 route product structure diagram
    ACUEFQ687188527-08-4 In Stock
Inquiry

2. ACUEFQ687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7 In Stock
  4. Then
  5. ACUEFQ687 route product structure diagram
    ACUEFQ687188527-08-4 In Stock
Inquiry

Comments (0)